Neurodegeneration is the process of slow neuronal death that is at the core of diseases such as ALS, Parkinson’s, Alzheimer’s and even Multiple Sclerosis. GenrAb is harnessing the power of the human immune system to develop therapies that can protect and treat patients with neurological disease. Developing neuroprotective agents will provide patients the next generation of treatment that can prevent the progression of disease and allow for new approaches to their care.